“Vascular Response to Everolimus- and Biolimus-Eluting Coronary Stents Versus Everolimus-Eluting Bioresorbable Scaffolds – an Optical Coherence Tomography Substudy of the EVERBIO II Trial”. Swiss Medical Weekly 146, no. 0102 (January 3, 2016): w14274. Accessed October 29, 2025. https://smw.ch/index.php/smw/article/view/2139.